Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin Resistance
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin Resistance
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 12, Pages 7601-7605
Publisher
American Society for Microbiology
Online
2014-10-07
DOI
10.1128/aac.04134-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates
- (2014) Gregory A. Eschenauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia
- (2014) N. D. Beyda et al. CLINICAL INFECTIOUS DISEASES
- Undiagnosed invasive candidiasis: incorporating non-culture diagnostics into rational prophylactic and preemptive antifungal strategies
- (2014) Cornelius J Clancy et al. Expert Review of Anti-Infective Therapy
- Candida glabrata Intra-Abdominal Candidiasis Is Characterized by Persistence within the Peritoneal Cavity and Abscesses
- (2014) Shaoji Cheng et al. INFECTION AND IMMUNITY
- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
- (2013) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure
- (2013) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for IdentifyingFKSMutant Candida glabrata Strains and Echinocandin Resistance
- (2013) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- The Presence of anFKSMutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata
- (2012) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
- (2012) D. R. Andes et al. CLINICAL INFECTIOUS DISEASES
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Distribution of micafungin in the tissue fluids of patients with invasive fungal infections
- (2011) Noriaki Yamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Candida Peritonitis: An Update on the Latest Research and Treatments
- (2011) Herman Anthony Carneiro et al. WORLD JOURNAL OF SURGERY
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
- (2008) Brahm H. Segal et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started